The challenges of treating a patient with recurrent congenital toxoplasmic chorioretinitis

1Maldonado YA, Read JS. Committee on Infectious Diseases. Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics. 2017;139(2):e20163860; DOI:10.1542/peds.2016-3860. Maldonado YA Read JS Committee on Infectious Diseases Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics 2017 139 2 e20163860 10.1542/peds.2016-386028138010Open DOISearch in Google Scholar

2European Centre for Disease Prevention and Control. Congenital toxoplasmosis. In: ECDC. Annual epidemiological report for 2016. Stockholm:ECDC. 2019. European Centre for Disease Prevention and Control Congenital toxoplasmosis In ECDC. Annual epidemiological report for 2016. Stockholm:ECDC 2019Search in Google Scholar

3Ozgonul C, Besirli CG. Recent Developments in the Diagnosis and Treatment of Ocular Toxoplasmosis. Ophthalmic Res. 2017;57(1):1–12; DOI:10.1159/000449169. Ozgonul C Besirli CG Recent Developments in the Diagnosis and Treatment of Ocular Toxoplasmosis Ophthalmic Res 2017 57 1 1 12 10.1159/00044916927723657Open DOISearch in Google Scholar

4McLeod R, Boyer K. Toxoplasmosis (Toxoplasma gondii). In: Kliegman RA, St Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM , Behrman RE, editors. Nelson Textbook of Pediatrics. 21th ed. Philadelphia: Elsevier Health Sciences. 2019;316:1865-1877. McLeod R Boyer K Toxoplasmosis (Toxoplasma gondii) In: Kliegman RA, St Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM , Behrman RE, editors. Nelson Textbook of Pediatrics. 21th ed. Philadelphia: Elsevier Health Sciences 2019 3161865 187710.1016/B978-1-4377-0755-7.00282-7Search in Google Scholar

5Park Y-H, Nam H-W. Clinical Features and Treatment of Ocular Toxoplasmosis. Korean J Parasitol. 2013;51(4):393–9; DOI:10.3347/kjp.2013.51.4.393. Park Y-H Nam H-W Clinical Features and Treatment of Ocular Toxoplasmosis Korean J Parasitol 2013 51 4 393 9 10.3347/kjp.2013.51.4.393377086924039281Open DOISearch in Google Scholar

6Muñoz-Roldan M, Heimesaat MM, Liesenfeld O. Toxoplasmosis. In: Manson’s Tropical Infectious Diseases. Elsevier. 2014;652-663; DOI:10.1016/B978-0-7020-5101-2.00049-2. Muñoz-Roldan M Heimesaat MM Liesenfeld O Toxoplasmosis. In: Manson’s Tropical Infectious Diseases Elsevier 2014 652 663 10.1016/B978-0-7020-5101-2.00049-2Open DOISearch in Google Scholar

7Giugno S, Monteleone MM, Insalaco G, Leanza G, Palumbo M, Leanza V. Congenital toxoplasmotic chorioretinitis following reinfection. Eur J Obstet Gynecol Reprod Biol. 2020; 251:263-265; DOI:10.1016/j. ejogrb.2020.04.045. Giugno S Monteleone MM Insalaco G Leanza G Palumbo M Leanza V Congenital toxoplasmotic chorioretinitis following reinfection Eur J Obstet Gynecol Reprod Biol 2020 251263 265 10.1016/j.ejogrb.2020.04.04532536466Open DOISearch in Google Scholar

8Sáfadi MAP, Berezin EN, Farhat CK, Carvalho ES. Clinical presentation and follow up of children with congenital toxoplasmosis in Brazil. Braz J Infect Dis. 2003;7(5); DOI:10.1590/S1413-86702003000500007. Sáfadi MAP Berezin EN Farhat CK Carvalho ES Clinical presentation and follow up of children with congenital toxoplasmosis in Brazil Braz J Infect Dis 2003 7 5 10.1590/S1413-86702003000500007Open DOISearch in Google Scholar

9Feliciano-Alfonso JE, Vargas-Villanueva A, Marin MA, Trivino L, Carvajal N, Moreno M, Luna T, Lopez de Mesa C, Muñoz-Ortiz J, de-la-Torre A. Antibiotic treatment for ocular toxoplasmosis: a systematic review and meta-analysis: study protocol. Syst Reviews 8. 2019;146; DOI:10.1186/s13643-019-1067-8. Feliciano-Alfonso JE Vargas-Villanueva A Marin MA Trivino L Carvajal N Moreno M Luna T Lopez de Mesa C Muñoz-Ortiz J de-la-Torre A Antibiotic treatment for ocular toxoplasmosis: a systematic review and meta-analysis: study protocol Syst Reviews 8 2019 146 10.1186/s13643-019-1067-8658723931221217Open DOISearch in Google Scholar

10Kaye A. Toxoplasmosis: Diagnosis, Treatment, and Prevention in Congenitally Exposed Infants. J Pediatr Health Care. 2011;25(6):355–64; DOI:10.1016/j.pedhc.2010.04.008. Kaye A Toxoplasmosis: Diagnosis, Treatment, and Prevention in Congenitally Exposed Infants J Pediatr Health Care 2011 25 6 355 64 10.1016/j.pedhc.2010.04.00822018426Open DOISearch in Google Scholar

11Jones JL, Ogunmodede F, Scheftel J, Kirkland E, Lopez A, Schulkin J, Lynfield R. Toxoplasmosis-Related Knowledge and Practices Among Pregnant Women in the United States. Infect Dis Obstet Gynecol. 2003;11(3):139–45; DOI:10.1080/10647440300025512. Jones JL Ogunmodede F Scheftel J Kirkland E Lopez A Schulkin J Lynfield R Toxoplasmosis-Related Knowledge and Practices Among Pregnant Women in the United States Infect Dis Obstet Gynecol 2003 11 3 139 45 10.1080/10647440300025512185228015022874Open DOISearch in Google Scholar

12Oray M, Ozdal PC, Cebeci Z, Kir N, Tugal-Tutkun I. Fulminant Ocular Toxoplasmosis: The Hazards of Corticosteroid Monotherapy. Ocul Immunol Inflamm. 2016;24(6):637-646; DOI:10.3109/09273948.2015.1 057599. Oray M Ozdal PC Cebeci Z Kir N Tugal-Tutkun I Fulminant Ocular Toxoplasmosis: The Hazards of Corticosteroid Monotherapy Ocul Immunol Inflamm 2016 24 6 637 646 10.3109/09273948.2015.105759926647176Open DOISearch in Google Scholar

13Soheilian M, Ramezani A, Azimzadeh A, Sadoughi MM, Dehghan MH, Shahghadami R, Yaseri M, Peymanet GA. Randomized Trial of Intravitreal Clindamycin and Dexamethasone versus Pyrimethamine, Sulfadiazine, and Prednisolone in Treatment of Ocular Toxoplasmosis. Ophthalmology. 2011;118(1):134–41; DOI:10.1016/j.ophtha.2010.04.020. Soheilian M Ramezani A Azimzadeh A Sadoughi MM Dehghan MH Shahghadami R Yaseri M Peymanet GA Randomized Trial of Intravitreal Clindamycin and Dexamethasone versus Pyrimethamine, Sulfadiazine, and Prednisolone in Treatment of Ocular Toxoplasmosis Ophthalmology 2011 118 1 134 41 10.1016/j.ophtha.2010.04.02020708269Open DOISearch in Google Scholar

14Prednisone: Drug information [Internet]. UpToDate: Lexicomp; Copyright 1978-2021. Prednisone [cited 10 May 2021]. Available from: https://www.uptodate.com/contents/prednisone-drug-information?topicRef=850&source=see_link Prednisone: Drug information [Internet] UpToDate: Lexicomp; Copyright 1978-2021 Prednisone [cited 10 May 2021]. Available from https://www.uptodate.com/contents/prednisone-drug-information?topicRef=850&source=see_linkSearch in Google Scholar